Adderall, the premier pharmaceutical prescribed for treatment of ADHD in many Americans, has recently had its effectiveness called into question. With a long history of providing focus to those who suffer from ADHD, it has historically been thought of as a wonder drug with proven and consistent results. Now those long held beliefs are being threatened after the revelation that president Trump is a frequent user of this product.
While providing the ability to focus has been its main advantage, the actions of the president indicate that its effect is not as reliable as commonly thought. The ability to think clearly is missing from many of the actions he takes, and this concerns the medical community that maybe there are limits to its ability to provide the intended results.
Although Adderall can be prescribed for children as young as 3 years old, there is reason to believe that brain development might play a part in the current situation. In original studies used to determine the guidelines for the drugs usage, observations were made which indicated that the drug provided no significant benefits in brain development lower than that stage.
FDA recommendations at this time are that the current users of Adderall continue to maintain their daily drug therapy. They have however advised that if the maturity level of the patient is lower than 3 years old, that the drug be stopped.
It is also recommended that the drug not being taken outside of its prescribed method, nasal snorting of the drug will result in sniffles and periods of twitter rage.